Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

NCT00396175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: MK0906, finasteride / Duration of Treatment : 48 Weeks
DRUG: Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks

Sponsor

Organon and Co